Cargando…
HDAC6-dependent deacetylation of TAK1 enhances sIL-6R release to promote macrophage M2 polarization in colon cancer
Histone deacetylase 6 (HDAC6), a member of the HDAC family, has been identified as a potential therapeutic target for tumor therapy, but the function and underlying mechanisms of HDAC6 in colon cancer are incompletely characterized. Our study showed that the infiltration ratio of M2 macrophages was...
Autores principales: | Xu, Guangying, Niu, Liling, Wang, Youhui, Yang, Guang, Zhu, Xingwu, Yao, Yuan, Zhao, Gang, Wang, Shaowei, Li, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587286/ https://www.ncbi.nlm.nih.gov/pubmed/36270986 http://dx.doi.org/10.1038/s41419-022-05335-1 |
Ejemplares similares
-
Loss of Deacetylation Activity of Hdac6 Affects Emotional Behavior in Mice
por: Fukada, Masahide, et al.
Publicado: (2012) -
aPKC Phosphorylation of HDAC6 Results in Increased Deacetylation Activity
por: Du, Yifeng, et al.
Publicado: (2015) -
Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6
por: Vanaja, G. R., et al.
Publicado: (2018) -
Deacetylation of α-tubulin and cortactin is required for HDAC6 to trigger ciliary disassembly
por: Ran, Jie, et al.
Publicado: (2015) -
The ubiquitin ligase E6AP facilitates HDAC6-mediated deacetylation and degradation of tumor suppressors
por: Zhang, Yanan, et al.
Publicado: (2020)